Money

Roche is investing in new cancer-fighting technology, and some of Big Pharma's CEOs notched some noteworthy pa…

Johnson & Johnson leaders have laid out a plan to reach record revenue this year while opening the door to…

Terremoto says that its AKT1 blockers can overcome toxicity challenges associated with PI3K/AKT inhibitors thr…

The XBI is up 30% in six months, beating the S&P 500 by 24 percentage points — and the gap only widened in Apr…

Several of pharma’s top leaders scored large pay bumps last year, including two new chiefs who joined th…

Biotech IPOs gain long-lost momentum, and pharma companies find a way around the White House’s harsh tar…